These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 28341360)
1. Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia. Pokorney SD; Mi X; Hammill BG; Allen LaPointe NM; Curtis LH; Al-Khatib SM Am J Cardiol; 2017 May; 119(9):1401-1406. PubMed ID: 28341360 [TBL] [Abstract][Full Text] [Related]
2. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444 [TBL] [Abstract][Full Text] [Related]
3. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. AbdelWahab A; Sapp J Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864 [TBL] [Abstract][Full Text] [Related]
4. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727 [TBL] [Abstract][Full Text] [Related]
5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
6. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator]. Tiroke A; Ganeeva ON Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312 [TBL] [Abstract][Full Text] [Related]
7. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221 [TBL] [Abstract][Full Text] [Related]
8. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs? Ferrari R; Cinca J; Marber M Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339 [No Abstract] [Full Text] [Related]
9. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140 [TBL] [Abstract][Full Text] [Related]
10. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150 [TBL] [Abstract][Full Text] [Related]
11. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. Ho AT; Pai SM; Timothy P; Pai RG Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799 [TBL] [Abstract][Full Text] [Related]
12. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. Leite LR; Fenelon G; Simoes A; Silva GG; Friedman PA; de Paola AA J Cardiovasc Electrophysiol; 2003 Jun; 14(6):567-73. PubMed ID: 12875414 [TBL] [Abstract][Full Text] [Related]
14. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. Connolly SJ; Dorian P; Roberts RS; Gent M; Bailin S; Fain ES; Thorpe K; Champagne J; Talajic M; Coutu B; Gronefeld GC; Hohnloser SH; JAMA; 2006 Jan; 295(2):165-71. PubMed ID: 16403928 [TBL] [Abstract][Full Text] [Related]
15. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Droogan C; Patel C; Yan GX; Kowey PR Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
17. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
18. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease). Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400 [TBL] [Abstract][Full Text] [Related]
19. Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease. Rassi FM; Minohara L; Rassi A; Correia LCL; Marin-Neto JA; Rassi A; da Silva Menezes A JACC Clin Electrophysiol; 2019 Oct; 5(10):1213-1223. PubMed ID: 31648747 [TBL] [Abstract][Full Text] [Related]
20. Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete? Cooley R; Akhtar M; Sra J Curr Cardiol Rep; 1999 Nov; 1(4):268-73. PubMed ID: 10980853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]